Publication | Closed Access

Dasatinib attenuates overexpression of Src signaling induced by the combination treatment of veliparib plus carboplatin in triple-negative breast cancer

Breast OncologyMedicineCombination TreatmentCancer BiologyBreast CancerTriple-negative Breast CancerCell BiologyCancer TreatmentOncologyRadiation OncologyTumor BiologyCancer Growth